We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Diabesity in Elderly Cardiovascular Disease Patients: Mechanisms and Regulators.
- Authors
García-Vega, David; González-Juanatey, José Ramón; Eiras, Sonia
- Abstract
Cardiovascular disease (CVD) is the leading cause of death in the world. In 2019, 550 million people were suffering from CVD and 18 million of them died as a result. Most of them had associated risk factors such as high fasting glucose, which caused 134 million deaths, and obesity, which accounted for 5.02 million deaths. Diabesity, a combination of type 2 diabetes and obesity, contributes to cardiac, metabolic, inflammation and neurohumoral changes that determine cardiac dysfunction (diabesity-related cardiomyopathy). Epicardial adipose tissue (EAT) is distributed around the myocardium, promoting myocardial inflammation and fibrosis, and is associated with an increased risk of heart failure, particularly with preserved systolic function, atrial fibrillation and coronary atherosclerosis. In fact, several hypoglycaemic drugs have demonstrated a volume reduction of EAT and effects on its metabolic and inflammation profile. However, it is necessary to improve knowledge of the diabesity pathophysiologic mechanisms involved in the development and progression of cardiovascular diseases for comprehensive patient management including drugs to optimize glucometabolic control. This review presents the mechanisms of diabesity associated with cardiovascular disease and their therapeutic implications.
- Subjects
CARDIOVASCULAR diseases; OLDER patients; HEART diseases; TYPE 2 diabetes; ATRIAL fibrillation; CORONARY artery disease; RIMONABANT
- Publication
International Journal of Molecular Sciences, 2022, Vol 23, Issue 14, p7886
- ISSN
1661-6596
- Publication type
Article
- DOI
10.3390/ijms23147886